Literature DB >> 29346653

Emergence of acute/subacute infant-juvenile paracoccidioidomycosis in Northeast Argentina: Effect of climatic and anthropogenic changes?

Gustavo Giusiano1, Clarisa Aguirre2, Claudia Vratnica3, Florencia Rojas1, Teresa Corallo2, María Emilia Cattana1, Mariana Fernández1, Javier Mussin1, María de Los Angeles Sosa1,4.   

Abstract

Argentina has two endemic areas of paracoccidioidomycosis (PCM). Bordering Paraguay and Brazil, Northeast Argentina (NEA) comprises the area with the highest incidence where the chronic adult clinical form has historically been reported. Juvenile form in children and adolescents is rare in this area since only one case was reported in the last 10 years. Despite this, between 2010 and 2012, several cases of acute/subacute clinical forms in children aged 10 to 16 (median 12) were detected. In the last decade, the NEA region has been exposed to ecological variations as consequences of certain climatic and anthropogenic changes, including El Niño-Southern Oscillation phenomenon during 2009, and deforestation. The region has also suffered from the significant ecological effects of the construction of one of the biggest hydroelectric dams of South America. This study aims to describe clinical and epidemiological aspects of acute/subacute PCM cases detected in children from NEA and to discuss climatic and anthropogenic changes as possible contributing factors in the emergence of this disease in children. This acute/subacute PCM cluster was characterized by severe disseminated and aggressive presentations to localized form, with a high spectrum of clinical manifestations uncommonly observed. Due to the lack of experience in acute/subacute PCM in children in the studied area and the atypical clinical manifestations observed, the diagnosis was delayed. In order to avoid misdiagnosis, a higher level of suspicion is now required in NEA and countries bordering the southern part of the endemic area, which are affected by the changes discussed in this article.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29346653     DOI: 10.1093/mmy/myx153

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  4 in total

1.  Genomic diversity of the human pathogen Paracoccidioides across the South American continent.

Authors:  Marcus de Melo Teixeira; Maria Emilia Cattana; Daniel R Matute; José F Muñoz; Alicia Arechavala; Kristin Isbell; Rafael Schipper; Gabriela Santiso; Fernanda Tracogna; María de Los Ángeles Sosa; Norma Cech; Primavera Alvarado; Laura Barreto; Yone Chacón; Juana Ortellado; Cleoni Mendes de Lima; Marilene Rodrigues Chang; Gustavo Niño-Vega; Maria Aparecida Shikanai Yasuda; Maria Sueli Soares Felipe; Ricardo Negroni; Christina A Cuomo; Bridget Barker; Gustavo Giusiano
Journal:  Fungal Genet Biol       Date:  2020-04-20       Impact factor: 3.495

2.  Clinical and Eco-Epidemiological Aspects of a Novel Hyperendemic Area of Paracoccidioidomycosis in the Tocantins-Araguaia Basin (Northern Brazil), Caused by Paracoccidioides sp.

Authors:  Alessandra G Krakhecke-Teixeira; Danielle H Yamauchi; Alexsandra Rossi; Herdson R de Sousa; Hans G Garces; Joaquim L Júnior; Antônio O S Júnior; Maria Sueli S Felipe; Eduardo Bagagli; Heitor F de Andrade; Marcus de M Teixeira
Journal:  J Fungi (Basel)       Date:  2022-05-12

3.  Molecular eco-epidemiology of Paracoccidioides brasiliensis in road-killed mammals reveals Cerdocyon thous and Cuniculus paca as new hosts harboring this fungal pathogen.

Authors:  Bruno de Souza Scramignon-Costa; Fernando Almeida-Silva; Bodo Wanke; Marcelo Weksler; Ricardo Moratelli; Antonio Carlos Francesconi do Valle; Rosely Maria Zancopé-Oliveira; Rodrigo Almeida-Paes; Cecília Bueno; Priscila Marques de Macedo
Journal:  PLoS One       Date:  2021-08-24       Impact factor: 3.240

4.  Serological diagnosis of paracoccidioidomycosis using a Paracoccidioides spp. comercial antigen and the counterimmunoelectrophoresis method.

Authors:  Tiago Alexandre Cocio; Roberto Martinez
Journal:  Braz J Infect Dis       Date:  2021-09-01       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.